HAEMONETICS CORP — Director's Dealing 2015

Jul 7, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2015-07-02

Reporting Person: White Jonathan (Chief Science and Technology)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-07-02	Common Stock	S	2385.0	$41.14	Disposed	25620	Direct

Footnotes

F1: Pursuant to a 10b5-1 Plan.